Cargando…
Inpatient Hospital Costs for COVID-19 Patients in the United States
INTRODUCTION: Reliable cost and resource use data for COVID-19 hospitalizations are crucial to better inform local healthcare resource decisions; however, available data are limited and vary significantly. METHODS: COVID-19 hospital admissions data from the Premier Healthcare Database were evaluated...
Autores principales: | Ohsfeldt, Robert L., Choong, Casey Kar-Chan, Mc Collam, Patrick L., Abedtash, Hamed, Kelton, Kari A., Burge, Russel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491188/ https://www.ncbi.nlm.nih.gov/pubmed/34609704 http://dx.doi.org/10.1007/s12325-021-01887-4 |
Ejemplares similares
-
Cost-Effectiveness of Baricitinib Compared With Standard of Care: A Modeling Study in Hospitalized Patients With COVID-19 in the United States
por: Ohsfeldt, Robert, et al.
Publicado: (2021) -
Cost-Effectiveness of Combination of Baricitinib and Remdesivir in Hospitalized Patients with COVID-19 in the United States: A Modelling Study
por: Kelton, Kari, et al.
Publicado: (2021) -
Comparative Effectiveness of Dexamethasone in Hospitalized COVID-19 Patients in the United States
por: Choong, Casey Kar-Chan, et al.
Publicado: (2022) -
Inpatient cost of treating osteoporotic fractures in mainland China: a descriptive analysis
por: Yang, Yicheng, et al.
Publicado: (2015) -
Challenges in Evaluating the Cost-Effectiveness of Statins
por: Ohsfeldt, Robert L.
Publicado: (2004)